Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001209191-19-048672

Chief Medical Officer sold 343 shares at $33.92 ($11,635)

  • Chief Medical Officer acquired 1,041 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schoenberg Mark · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-04 Exercise or conversion : show line 1 in the form +1,041 6,350 D
2019-09-04 Sale : show line 2 in the form −343 $33.92 $11,635 6,007 D
Open-market sales · 343 sh · avg $33.92 · $11,635

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2019-09-04 Exercise or conversion : show line 3 in the form Restricted Stock Units (RSUs) −1,041 1,041 5,209 D
Loading xslF345X03/doc4.xml…